A detailed history of Fin Trust Capital Advisors, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 10,000 shares of VRCA stock, worth $79,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$79,500
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$7.95 - $7.95 $79,500 - $79,500
10,000 New
10,000 $79,000
Q4 2020

Feb 16, 2021

SELL
$7.41 - $12.63 $74,100 - $126,300
-10,000 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$6.16 - $10.3 $61,600 - $103,000
10,000 New
10,000 $77,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.